Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Scully

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Phlebology|December 7, 2020
Venous malformations: Coagulopathy control and treatment methodsEleanor J Budge, Muhammad Aa Khalil Allam, Imogen Mechie, et al.
Blood|June 4, 2011
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpuraMarie Scully, Vickie McDonald, Jamie Cavenagh, et al.
British Journal of Haematology|September 12, 2015
The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP RegistrySevda Hassan, John-Paul Westwood, Debra Ellis, et al.
ERJ Open Research|January 6, 2017
The role of complement activation in COPD exacerbation recoveryJohn-Paul Westwood, Alexander J Mackay, Gavin Donaldson, et al.
Research and Practice in Thrombosis and Haemostasis|April 17, 2023
ADAMTS13 activity testing: evaluation of commercial platforms for diagnosis and monitoring of thrombotic thrombocytopenic purpuraDeepak Singh, Maryam Owais Subhan, Rens de Groot, et al.
Blood Advances|May 4, 2022
Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpuraJin-Sup Shin, Maryam Owais Subhan, Geraldine Cambridge, et al.
British Journal of Haematology|January 20, 2007
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13Marie Scully, Hannah Cohen, Jamie Cavenagh, et al.
Journal of Clinical Medicine|November 26, 2022
Pitfalls in Diagnosing Thrombotic Thrombocytopenic Purpura in Sickle Cell DiseaseDimitris A Tsitsikas, Diana Mihalca, John Hall, et al.
Nephron|September 13, 2021
Pregnancy in Women with Atypical Hemolytic Uremic SyndromeEric Rondeau, Gianluigi Ardissino, Marie-Pierre Caby-Tosi, et al.
Blood|March 19, 2024
Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpuraNithya Prasannan, Bertina Dragunaite, Maryam Subhan, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Phlebology|December 7, 2020
Venous malformations: Coagulopathy control and treatment methodsEleanor J Budge, Muhammad Aa Khalil Allam, Imogen Mechie, et al.
Blood|June 4, 2011
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpuraMarie Scully, Vickie McDonald, Jamie Cavenagh, et al.
British Journal of Haematology|September 12, 2015
The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP RegistrySevda Hassan, John-Paul Westwood, Debra Ellis, et al.
ERJ Open Research|January 6, 2017
The role of complement activation in COPD exacerbation recoveryJohn-Paul Westwood, Alexander J Mackay, Gavin Donaldson, et al.
Research and Practice in Thrombosis and Haemostasis|April 17, 2023
ADAMTS13 activity testing: evaluation of commercial platforms for diagnosis and monitoring of thrombotic thrombocytopenic purpuraDeepak Singh, Maryam Owais Subhan, Rens de Groot, et al.
Blood Advances|May 4, 2022
Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpuraJin-Sup Shin, Maryam Owais Subhan, Geraldine Cambridge, et al.
British Journal of Haematology|January 20, 2007
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13Marie Scully, Hannah Cohen, Jamie Cavenagh, et al.
Journal of Clinical Medicine|November 26, 2022
Pitfalls in Diagnosing Thrombotic Thrombocytopenic Purpura in Sickle Cell DiseaseDimitris A Tsitsikas, Diana Mihalca, John Hall, et al.
Nephron|September 13, 2021
Pregnancy in Women with Atypical Hemolytic Uremic SyndromeEric Rondeau, Gianluigi Ardissino, Marie-Pierre Caby-Tosi, et al.
Blood|March 19, 2024
Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpuraNithya Prasannan, Bertina Dragunaite, Maryam Subhan, et al.
Pageof 16